統計三十三個國家膀胱癌對於性別及發生死亡比與國家醫療保健支出的關係
趙浩堅、陳順郎、高育琳、王紹全、陳文榮、謝佐宜、宋文瑋
中山醫學大學泌尿科
The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countries
Hao-chien Chao, Sung-Lang Chen, Yu-Lin Kao, Shao-Chung Wang, Wen-Jung Chen, Tzuo-Yi Hsieh,
Wen-Wei Sung
Department of Urology, Chung Shan Medical University Hospital, Taichung City, Taiwan
Purpose: The variation in the mortality-to-incidence ratio (MIR) between countries and genders reflects the complex etiology and intervention of bladder cancer. We assess the MIR of bladder cancer among disparities in health care among and that the gender difference.
Materials and Methods:We obtained cancer epidemiologic data from the GLOBOCAN 2012 database which is maintained by the International Agency for Research on Cancer. Health care expenditures and life expectancies were obtained from WHO’s World Health Statistics 2015, and the WHO rankings were obtained from WHO’s World’s Health Systems. Thirty-three countries were enrolled. We evaluated the association between the MIRs and variants using linear regression and SPSS statistical software.
Results: The high crude rate of bladder cancer incidence and mortality in more developed regions, Europe, and the Americas,but MIR is high in less developed country(Germany has the lowest MIR ratio in bladder cancer). The gender difference for the MIR in bladder cancer was evident in countries distributed on different continents. World Health Organization ranking and total expenditure on health/GDP are significantly associated with the mortality-to-incidence ratios in bladder cancer
Conclusions: Bladder cancer MIRs are associated with the ranking of health care systems and health care expenditures. Besides, the gender difference observed in the incidence and mortality of bladder cancer is an important issue.